Evidence map›Paper›PMID 42306396›Full record

ArticleCureus2026

Safety-Constrained Agentic AI for Autism Screening: A Multimodal, Clinician-Guided Architecture.

Debashis Patra, Ambar N Saha, Som S Mukherjee

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Debashis PatraArtificial Intelligence and Machine Learning, The University of Texas at Austin, Woodstock, USA.
Ambar N SahaInformation Technology/Software Engineering, Cognizant Technology Solution, Halifax, CAN.
Som S MukherjeeInformation Technology/Software Engineering, Projee, Inc, Woodstock, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autism spectrum disorder (ASD) diagnosis often encounters substantial delays due to several reasons, such as shortages of trained specialists and limited access to care in rural and underserved communities. Moreover, it is very difficult to perform behavioral assessments within a single clinical visit, as it is significantly dependent on the child's behavior. Delayed diagnosis can postpone early intervention, which is important for improving developmental outcomes in children with ASD. Although artificial intelligence (AI) is increasingly explored in healthcare, its adoption in ASD screening remains limited due to concerns about reliability, governance, consent management, bias, and clinical trust. In this work, we propose a conceptual, governance-driven, clinician-augmented AI framework designed to assist clinicians during the ASD screening process rather than replace them. The proposed architecture collects various inputs such as text, audio, and video of a child from parents, schools, or caregivers, and then it runs through multiple specialized agents who are responsible for consent validation, bias monitoring, model selection, confidence-based abstention, and providing a structured report which will help clinicians in their assessment. Caregivers receive only non-diagnostic guidance, while clinicians receive structured decision-support information designed to aid clinical evaluation. The main goal of this article is not to validate model performance. We are mainly trying to design an agentic framework where governance and safety rules can be managed properly through multiple specialized agents. Although we have performed a single model training using a ResNet-50 facial-image classification model on a publicly available dataset, our main goal was to validate the governance and multi-agent system. The Stage 1 governance validation was done using more than a hundred scenarios. It is very important to highlight that our article should be viewed as a conceptual governance-driven agentic framework with Stage 1 validation, and it is definitely not a fully workable clinical solution. In the next phases, we plan to collect clinically validated data and focus more on model training, multimodal integration, and real-world validation.

Indexed as

agentic aiai governanceautism screeningautism spectrum disorder (asd)clinical decision supportearly screeninghealthcare technologymultimodal machine learning

Identifiers

PMID42306396
PMCPMC13267059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.